Skip to main content
Delfa

Lead sponsor

Peking University First Hospital

2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.

2

Trials led

1

Ongoing

1,200

Total enrollment

2

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 4
1
Not applicable
1

Trials by status

Not yet recruiting
1
Completed
1

Trials led

TrialEligibility highlightPhaseStatusEnrollment
Rivastigmine Mini-Tablet for Alzheimer's DiseaseAlzheimer's diseaseN/ANot yet recruiting1,000
CAVADVascular or mixed dementiaPh 4Completed200